Quarterly report pursuant to Section 13 or 15(d)

Accumulated Other Comprehensive Income (Details)

v2.4.0.8
Accumulated Other Comprehensive Income (Details) (USD $)
In Thousands, unless otherwise specified
6 Months Ended
Jun. 30, 2014
Accumulated Other Comprehensive Income (Loss), Net [Rollforward]  
Beginning Balance $ 3,418 [1]
Other comprehensive income before reclassifications, net of tax (2,561) [2]
Amounts reclassified from accumulated other comprehensive income, net of tax (553) [2]
Net other comprehensive income (3,114)
Ending Balance 304 [1]
Accumulated Translation Adjustment
 
Accumulated Other Comprehensive Income (Loss), Net [Rollforward]  
Beginning Balance 1,371
Other comprehensive income before reclassifications, net of tax (1,613) [2]
Amounts reclassified from accumulated other comprehensive income, net of tax 0 [2]
Net other comprehensive income (1,613)
Ending Balance (242)
Accumulated Net Unrealized Investment Gain (Loss)
 
Accumulated Other Comprehensive Income (Loss), Net [Rollforward]  
Beginning Balance 2,047
Other comprehensive income before reclassifications, net of tax (948) [2]
Amounts reclassified from accumulated other comprehensive income, net of tax (553) [2]
Net other comprehensive income (1,501)
Ending Balance $ 546
[1] As of June 30, 2014 and December 31, 2013, total assets include $7.7 million and $6.7 million, respectively, and total liabilities include $13.5 million and $10.4 million, respectively, related to SciVac Ltd (“SciVac”), previously known as SciGen (I.L.) Ltd, a consolidated variable interest entity. SciVac’s consolidated assets are owned by SciVac and SciVac’s consolidated liabilities have no recourse against us. Refer to Note 5.
[2] Effective tax rate of 38.47%.